According to Fredda London in Temple’s Office of the Vice President of Research and Graduate studies, a number of biotech firms within the 611 Corridor KIZ will benefit from Gill’s research.
“Many of the students who work in Gill’s laboratory will seek employment locally.
Additionally, the ideas for industrial applications of cell signaling work and development of biomaterials and kits for retailing to academia that come from Gill’s lab will expand the capabilities of this zone,” she said.
To that end, Gill is sponsoring a yearlong series of seminars and workshops in which Temple faculty will be meeting with investigators from other 611 Corridor KIZ partner institutions to share ideas and research findings. In addition, Temple’s Office of Technology Transfer will be sponsoring follow-up workshops to explore possible commercialization of the data presented.
Additionally, The Fox School of Business’ Innovation and Entrepreneurship Institute received a grant of $150,000 to help support entrepreneurship in the life sciences.
“This new funding will enable Temple and its KIZ partners to link start-up companies in the medical, dental, pharmaceutical and bioengineering fields to resources such as incubation space, funding, mentoring and other research and business resources,” said Chris Pavlides, the IEI’s executive director.
Through KIZ, 1,446 jobs have been created and another 2,043 positions retained across the commonwealth. Seventy-eight new companies have also been established with the support of the KIZ program.
|